急性前葡萄膜炎的复发风险
这项来自新西兰单中心2008至2021年的回顾性队列研究纳入2092例急性前葡萄膜炎患者共2763眼,中位随访8.9年。同侧眼复发率为45.5%,对侧眼为27.3%;病毒性葡萄膜炎同侧复发风险最高而对侧复发风险最低。存在复发危险因素的患者应接受适当管理和咨询以减少视力丧失风险。
要点
- 急性前葡萄膜炎同侧眼复发率45.5%,对侧眼复发率27.3%。
- 病毒性葡萄膜炎10年同侧复发率44.9%最高,对侧复发率2.0%最低。
- 复发危险因素包括年龄较大、毛利族裔、亚裔、HLA-B27/炎症性关节炎和病毒性葡萄膜炎。
核心结论
- 约半数急性前葡萄膜炎患者会出现同侧眼复发,约四分之一会出现对侧眼复发。
- 病毒性葡萄膜炎患者同侧复发风险最高而对侧复发风险最低。
- 存在复发危险因素的患者应接受适当管理和咨询以降低视力丧失和葡萄膜炎并发症的风险。
研究设计与样本
- 来自单一三级眼科临床中心的回顾性队列研究。
- 研究对象为2008年至2021年间在Te Whatu Ora(新西兰奥克兰)炎症性眼病数据库中被识别出的全部急性前葡萄膜炎患者。
- 通过病历回顾和电子患者记录回顾性收集研究期间所有患者的数据。
- 共纳入2092例受试者的2763眼,中位随访8.9年,总随访19794.9眼年。
- 采用Kaplan-Meier估计量报告复发率,采用边际Cox回归模型进行复发危险因素的多变量分析。
主要发现
- 同侧眼复发1258眼(45.5%),对侧眼复发522眼(27.3%)。
- 10年同侧复发率:特发性疾病38.1%,HLA-B27/炎症性关节炎43.2%,病毒性葡萄膜炎44.9%。
- 多变量分析中与同侧复发风险增加相关的因素:年龄较大(P < 0.001)、毛利族裔(P = 0.006)、亚裔(P < 0.001)、HLA-B27/炎症性关节炎(P < 0.001)、病毒性葡萄膜炎(P = 0.018)。
- 与性别、吸烟、双眼受累或高血压性葡萄膜炎无关联。
- 10年对侧眼受累率:特发性葡萄膜炎15.2%,HLA-B27/炎症性关节炎37.6%,病毒性葡萄膜炎2.0%;对侧眼受累危险因素为毛利族裔(P = 0.003)、太平洋岛民族裔(P = 0.021)和HLA-B27/炎症性关节炎(P < 0.001)。
关键数值与推荐
- 主要结局指标为疾病复发。
- 次要结局指标为中度视力丧失(≤20/50)。
临床怎么用
- 原文结论指出,存在复发危险因素的患者应接受适当管理和咨询以尽量减少视力丧失和葡萄膜炎并发症的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine the frequency of recurrence and identify risk factors for recurrence in patients with acute anterior uveitis (AAU). DESIGN: Retrospective cohort study from a single tertiary ophthalmic clinical center. PARTICIPANTS: All subjects with AAU identified from a database of Inflammatory Eye Disease presenting to Te Whatu Ora (Auckland, New Zealand) between 2008 and 2021. METHODS: Data were collected retrospectively from chart review and electronic patient records for all patients during the study period. Rates of recurrence were reported using the Kaplan-Meier estimator. Multivariate analysis of risk factors for recurrence was calculated using a marginal Cox regression model. MAIN OUTCOME MEASURES: The primary outcome measure was disease recurrence. Secondary outcome measure was moderate vision loss (≤20/50). RESULTS: A total of 2763 eyes of 2092 subjects with AAU were studied, with a median follow-up time of 8.9 years and a total follow-up of 19 794.9 eye-years. Recurrence occurred in the ipsilateral eye in 1258 eyes (45.5%) and in the contralateral eye in 522 eyes (27.3%). Rates of ipsilateral recurrence over 10 years were 38.1% for idiopathic disease, 43.2% for human leukocyte antigen B27 (HLA-B27)/inflammatory arthritis, and 44.9% for viral uveitis. On multivariate analysis, the following were associated with increased risk of ipsilateral recurrence: older age (P < 0.001), Māori ethnicity (P = 0.006), Asian ethnicity (P < 0.001), HLA-B27/inflammatory arthritis (P < 0.001), and viral uveitis (P = 0.018). There was no association with gender, smoking, bilateral disease, or hypertensive uveitis. Rates of contralateral eye involvement were significantly lower than ipsilateral eye recurrence. Contralateral recurrence at 10 years was 15.2% in idiopathic uveitis, 37.6% in HLA-B27/inflammatory arthritis, and 2.0% in viral uveitis. Risk factors identified for contralateral eye involvement were Māori ethnicity (P = 0.003), Pasifika (Pacific Islanders) ethnicity (P = 0.021), and HLA-B27/inflammatory arthritis (P < 0.001). Moderate vision loss (≤20/50) was present in 411 eyes (14.9%) at final follow-up and was more common if time to first recurrence was shorter (P < 0.001). CONCLUSIONS: Approximately half of patients with AAU will develop recurrence in the ipsilateral eye, and one-quarter will have recurrence in the contralateral eye. Patients with viral disease have the highest risk of ipsilateral recurrence and lowest risk of contralateral recurrence. Patients with risk factors for recurrence should be managed and counseled appropriately to minimize the risk of visual loss and complications of uveitis. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- Brodie JT, Thotathil AZ, Jordan CA, et al. Risk of Recurrence in Acute Anterior Uveitis. Ophthalmology. 2024. PMID: 38852922. doi:10.1016/j.ophtha.2024.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。